找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Alzheimer‘s Disease; Lit-Fui Lau,Michael A. Brodney Book 2008 Springer-Verlag Berlin Heidelberg 2008 Alzheimer.Medicinal Chemistry.Molecul

[复制链接]
楼主: Philanthropist
发表于 2025-3-25 03:49:50 | 显示全部楼层
Herwart Opitz,Hans Obrig,Karlheinz Ganseroid plaques and neurofibrillary tangles in the brain.There is a growing body of evidence to support a central role for biometals such as copper (Cu),zinc (Zn) and iron (Fe) in many critical aspects of AD and other neurodegenerative diseases. The amyloidbeta (Aβ) peptide and its parental molecule, th
发表于 2025-3-25 09:48:33 | 显示全部楼层
Herwart Opitz,Hans Obrig,Karlheinz Ganseriabetes mellitus, Alzheimer‘s disease, stroke, bipolardisorder and affective disorders. In the present review we briefly summarise the properties of GSK-3, focusingprimarily on the role of GSK-3 in Alzheimer‘s disease. Furthermore, we discuss the potential for therapeuticbenefit of GSK-3 inhibitors.
发表于 2025-3-25 14:12:39 | 显示全部楼层
,GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease,iabetes mellitus, Alzheimer‘s disease, stroke, bipolardisorder and affective disorders. In the present review we briefly summarise the properties of GSK-3, focusingprimarily on the role of GSK-3 in Alzheimer‘s disease. Furthermore, we discuss the potential for therapeuticbenefit of GSK-3 inhibitors.
发表于 2025-3-25 19:41:35 | 显示全部楼层
发表于 2025-3-25 21:15:25 | 显示全部楼层
978-3-642-09354-8Springer-Verlag Berlin Heidelberg 2008
发表于 2025-3-26 03:59:44 | 显示全部楼层
发表于 2025-3-26 04:40:32 | 显示全部楼层
Herwart Opitz,Hans Obrig,Karlheinz Ganseriabetes mellitus, Alzheimer‘s disease, stroke, bipolardisorder and affective disorders. In the present review we briefly summarise the properties of GSK-3, focusingprimarily on the role of GSK-3 in Alzheimer‘s disease. Furthermore, we discuss the potential for therapeuticbenefit of GSK-3 inhibitors.
发表于 2025-3-26 09:21:32 | 显示全部楼层
发表于 2025-3-26 14:25:54 | 显示全部楼层
发表于 2025-3-26 19:59:17 | 显示全部楼层
,Beyond Cholesterol: Statin Benefits in Alzheimer’s Disease,a. While early studies raised significant hopes, morerecent epidemiological studies suggest a more complex association between cholesterol, statin use andAD. Despite the controversy, prospective randomized placebo control studies in AD do support cognitive benefitfrom statin treatment. The managemen
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 14:08
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表